Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant.

Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant. Abstract Text:

    a A ,a m A M ,g brandhorstG Brandhorst,a heepA Heep,p bartmannP Bartmann,a r franzA R Franz,a müllerA Müller,a m eis-hübingerA M Eis-Hübinger,g brandhorstG Brandhorst,a heepA Heep,p bartmannP Bartmann,a r franzA R Franz,

    Cytomegalovirus (CMV) infection is the most important congenital viral infection. Intravenous (i.v.) Ganciclovir (GCV) improved outcome in term infants with symptomatic congenital CMV infection. We present data on oral valganciclovir (VGCV) in an extremely low birth weight infant.A male preterm infant was delivered at 28 weeks of gestation because of abnormal fetal perfusion with severe intrauterine growth retardation. The infant developed hepatitis and a severe thrombocytopenia. Serology revealed a positive CMV IgM in maternal serum 3 days after delivery and CMV DNA was detected in plasma and urine samples of the infants. Treatment with i.v. GCV was started at day 4 of life for 35 days and continued with oral VGCV for further 6 weeks. Plasma GCV levels were 1.68 ng ml(-1) (peak) and 0.92 ng ml(-1) (trough) on day 10 of oral treatment. Clinical signs resolved and virus load decreased slowly during therapy. At discharge brain stem-evoked audiometry was normal.Oral treatment with VGCV in an extremely low birth weight preterm infant with congenital CMV infection resulted in adequate GCV plasma levels, reduced effectively the CMV viral load and was well tolerated without apparent adverse effects.Journal of Perinatology (2008) 28, 74-76. doi:10.1038/sj.jp.7211854.

    Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant. Publishing Authors By Initials

    a A ,am AM ,g brandhorstG Brandhorst,a heepA Heep,p bartmannP Bartmann,ar franzAR Franz,a müllerA Müller,am eis-hübingerAM Eis-Hübinger,g brandhorstG Brandhorst,a heepA Heep,p bartmannP Bartmann,ar franzAR Franz,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Journal of perinatology : official journal of the

    VOLUME: 28

    Page Numbers: 74-6

    Journal Abbreviation:

    ISSN: 0743-8346

    DAY: 31

    MONTH: Jan

    YEAR: 2008

    Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8501884

    Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant.

    AFFILIATION: 1Department of Neonatology, Children's Hospital, University of Bonn, Bonn, Germany.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: J Perinatol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News